Gardado en:
Detalles Bibliográficos
Autor Principal: Graham, Jessina
Formato: Recurso digital
Idioma:
Publicado: Zenodo 2025
Subjects:
Acceso en liña:https://doi.org/10.5281/zenodo.15829186
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Table of Contents:
  • <p><strong>Title:</strong></p> <div> <p>Bioelectrical and Biological Pattern Failure Before Cell Death: A Recursive Diagnostic Terrain Model for Chronic Fatigue, Autonomic, and Immune Collapse in POTS, MCAS, ME/CFS, Autism, ADHD and Chronic Illness</p> <p>Patient and Provider Handouts with Clinical Walkthrough:</p> <p><a href="https://grahammedical.substack.com/p/bioelectric-and-redox-terrain-failure">https://grahammedical.substack.com/p/bioelectric-and-redox-terrain-failure</a></p> <p><strong>Description:</strong><br>This work presents the second layer in a recursive diagnostic terrain framework that redefines redox imbalance, methylation collapse, and purinergic amplification as early, actionable checkpoints in complex chronic illness. It builds upon the foundational terrain architecture introduced in:</p> <p><strong>Graham, J. (2025).</strong> <em>Intracellular Iron Deficiency and Mitochondrial Iron Miscompartmentalization as a Convergent Mechanism...</em> <a href="https://doi.org/10.5281/zenodo.15693226" target="_new" rel="noopener">https://doi.org/10.5281/zenodo.15693226 </a></p> <p>Here, ferroptotic bias is recast not as a terminal event but as a nutrient- and redox-sensitive terrain checkpoint that precedes immune, vascular, and autonomic collapse. This system stratifies collapse trajectories across PEM, ME/CFS, POTS, MCAS, Autism, ADHD and related disorders. This links biochemical and bioelectrical signals (e.g. P2X7/NLRP3 activation, glutathione depletion, D-dimer/VEGF elevation) to terrain-based diagnostics that are clinically actionable.</p> <p>The model integrates evolutionary physiology, redox and mitochondrial biology, and methylation dynamics to detect pre-symptomatic failure and define therapeutic inflection points. It incorporates Michael Levin’s bioelectrical patterning model to explain morphogenetic disarray and immune bifurcation as pattern memory loss.</p> <p><strong>Clinical Use & Licensing:</strong><br>Released under Creative Commons Attribution 4.0 International (CC BY 4.0) to support open access. A Scope and Clinical Use Declaration is embedded to define ethical and medico-legal parameters. While openly accessible, any clinical, translational, or derivative use requires full scope fidelity. Fragmented or decontextualized use risks iatrogenic harm, diagnostic misclassification, and therapeutic misdirection.</p> <p>This model is clinically actionable, recursive, non-theoretical, and diagnostically inseparable. It is a harm reduction tool.</p> <p><strong>Author Context:</strong><br>Developed by a credentialed clinician with a background in zoology, former bedside nurse, and disabled patient. This work unites layered clinical insight, evolutionary modeling, and lived experience into a single recursive diagnostic lens. It is unapologetically patient-first and epistemically non-fragmentable.</p> <p><strong>Ethics Statement:</strong></p> <p><em>“Nothing about us, without us.”</em></p> <p>Those who do not recognize patient agency have no agency in this discussion.</p> </div>